CAS: 90780-52-2; (4Z,7Z,10Z,13E,15E,19Z)-17-Hydroxydocosa-4,7,10,13,15,19-Hexaenoic Acid

该化合物是长碳链和多重双联结,特别是共6个,有助于其流动性和反应性.该化合物是多克己氧酸的衍生物,其作用在人类健康中,特别是在大脑和心血管功能中. 氢氧基(-OH)组的存在提高了其在极溶剂中的溶性,并可能影响其生物活动,包括抗炎特性.Z和E的称谓所显示的双重联结的具体形态影响其与生物膜和酶的相互作用.这种脂肪酸经常因其潜在的治疗作用,包括其在...

结构式图片

上下游产品

d°Cosahexaenoic acid (17S)-HDHA

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2010159540-A1
    优先权日:2007-03-26
    标题:Synthesis of resolvins and intermediates, compounds prepared thereby, and uses thereof
    发明人:RODRIGUEZ ANA; SPUR BERND
    权利人:RODRIGUEZ ANA; SPUR BERND
    摘要:Methods are disclosed for the preparation of a new class of lipid mediators known as resolvins, with Resolvin D6 (4,17-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid) being exemplary. Also disclosed are methods for the efficient synthesis of key intermediates in the preparation of such resolvins, such as isotopically labeled ω-3 fatty acid metabolites, and derivatives and analogs thereof. The invention likewise extends to the intermediates so prepared, and to the resolvins prepared with their use.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1002/eji.201545673
    摘要:Kim N, Ramon S, Thatcher TH, Woeller CF, Sime PJ, Phipps RP. Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production. Eur J Immunol. 2016 Jan;46(1):81–91.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知